PDS Biotechnology Corporation has announced the publication of three abstracts related to its investigational immunotherapy, Versamune® HPV (PDS0101), which will be presented at the upcoming 2025 ...

Head and neck cancer researchers are reporting the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for ...

The current HPV vaccine protects against nine strains of HPV, all of which have the potential to cause cancer: 6, 11, 16, 18, 31, 33, 45, 52, and 58. Strains 16 and 18 are the two associated with most ...

HPV is often considered a taboo subject. Although most of us will be exposed human papillomavirus (HPV) at some point in our lives, it remains widely misunderstood. Receiving a positive HPV result can ...

Researchers have found that human papillomavirus (HPV) vaccines are highly effective at reducing cervical cancer-causing infections and can offer herd immunity, reinforcing previous research and ...

The most common cancer-causing strain of human papillomavirus (HPV), HPV16, undermines the body’s defenses by reprogramming immune cells surrounding the tumor, according to new research from the Keck ...

{image id=1352663 align=left size=large byline=true caption="The Massachusetts General Hospital, home to Mass Eye and Ear and part of the Mass General Brigham system ...